Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia:: a stable isotope study

被引:0
|
作者
Frénais, R
Ouguerram, K
Maugeais, C
Marchini, JS
Benlian, P
Bard, JM
Magot, T
Krempf, M [1 ]
机构
[1] Hotel Dieu, Grp Metab, Ctr Rech Nutr Humaine, Nantes, France
[2] Sch Med Ribeirao Preto, Div Clin Nutr, Ribeirao Preto, Brazil
[3] Hop St Antoine, Serv Biochim, F-75571 Paris, France
[4] Hotel Dieu, Biochim Lab, Fac Pharm, Nantes, France
[5] Hotel Dieu, Clin Endocrinol, Nantes, France
关键词
heterozygous familial hypercholesterolemia; stable isotope; kinetic analysis; apo AI; HDL;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heterozygous familial hypercholesterolemia (FH) is associated with a moderate decrease of plasma apoA-I and HDL-cholesterol levels. The aim of the study was to test the hypothesis that these abnormalities were related to an increase of HDL-apoA-I fractional catabolic rate (FCR), We performed a 14-h infusion of [5,5,5-H-2(3)]leucine in seven control subjects and seven heterozygous FH patients (plasma total cholesterol 422 +/- 27 vs. 186 +/- 42 mg/dL, P < 0.001, respectively), Plasma apoA-I concentration was not changed in FH compared to controls (respectively 115 +/- 18 vs. 122 +/- 15 mg-/dL, NS), and HDL-cholesterol level was decreased (37 +/- 7 vs. 46 +/- 19 mg/dL, NS), Kinetics of HDL metabolism were modeled as a single compartment as no differences were observed between HDL2 and HDL3 subclasses. Both mean apoA-I FCR and absolute production rate (APR) were increased in FH (respectively, 0.36 +/- 0.14 vs. 0.22 +/- 0.05 pool/d, P < 0.05, and 18.0 +/- 7.7 and 11.2 +/- 2.3 mg/kg/d, P < 0.05), Higher HDL-triglyceride and HDL apoE levels were observed in patients with heterozygous FH, (Respectively 19 +/- 8 vs. 8 +/- 3 mg/dL, P < 0.05, and 5.3 +/- 0.8 vs. 3.7 +/- 0.9 mg/dL, P < 0.05). We conclude that the catabolism of HDL-apoA-I is increased in heterozygous FH patients, However, plasma apoA-I concentration was maintained because of an increased HDL-apoA-I production rate.
引用
收藏
页码:1506 / 1511
页数:6
相关论文
共 35 条
  • [1] High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study
    F Pont
    L Duvillard
    E Florentin
    P Gambert
    B Vergès
    International Journal of Obesity, 2002, 26 : 1151 - 1158
  • [2] High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients.: An in vivo stable isotope study
    Pont, F
    Duvillard, L
    Florentin, E
    Gambert, P
    Vergès, B
    INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (09) : 1151 - 1158
  • [3] Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia
    Tremblay, Andr J.
    Lamarche, Benoit
    Ruel, Isabelle L.
    Hogue, Jean-Charles
    Deshaies, Yves
    Gagne, Claude
    Couture, Patrick
    ATHEROSCLEROSIS, 2006, 188 (01) : 203 - 212
  • [4] INCREASED HEPATIC SECRETION OF VERY-LOW-DENSITY-LIPOPROTEIN APOLIPOPROTEIN B-100 IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - A STABLE-ISOTOPE STUDY
    CUMMINGS, MH
    WATTS, GF
    UMPLEBY, M
    HENNESSY, TR
    QUINEY, JR
    SONKSEN, PH
    ATHEROSCLEROSIS, 1995, 113 (01) : 79 - 89
  • [5] High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study
    R. Frénais
    K. Ouguerram
    C. Maugeais
    P. Mahot
    P. Maugère
    M. Krempf
    T. Magot
    Diabetologia, 1997, 40 : 578 - 583
  • [6] Metabolism of high density lipoprotein apolipoprotein A-I and cholesteryl ester in insulin resistant dog: a stable isotope study
    Briand, F.
    Bailhache, E.
    Nguyen, P.
    Krempf, M.
    Magot, T.
    Ouguerram, K.
    DIABETES OBESITY & METABOLISM, 2007, 9 (01) : 139 - 142
  • [7] High density lipoprotein apolipoprotein Al kinetics in NIDDM: A stable isotope study
    Frenais, R
    Ouguerram, K
    Maugeais, C
    Mahot, P
    Maugere, P
    Krempf, M
    Magot, T
    DIABETOLOGIA, 1997, 40 (05) : 578 - 583
  • [8] Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis
    Das, Madhurima
    Mei, Xiaohu
    Jayaraman, Shobini
    Atkinson, David
    Gursky, Olga
    FEBS JOURNAL, 2014, 281 (11) : 2525 - 2542
  • [9] INVIVO METABOLISM OF A MUTANT FORM OF APOLIPOPROTEIN A-I, APO A-I(MILANO), ASSOCIATED WITH FAMILIAL HYPOALPHALIPOPROTEINEMIA
    ROMA, P
    GREGG, RE
    MENG, MS
    RONAN, R
    ZECH, LA
    FRANCESCHINI, G
    SIRTORI, CR
    BREWER, HB
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1445 - 1452
  • [10] Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
    Karjalainen, Minna K.
    Holmes, Michael V.
    Wang, Qin
    Anufrieva, Olga
    Kahonen, Mika
    Lehtimaki, Terho
    Havulinna, Aki S.
    Kristiansson, Kati
    Salomaa, Veikko
    Perola, Markus
    Viikari, Jorma S.
    Raitakari, Olli T.
    Jarvelin, Marjo-Riitta
    Ala-Korpela, Mika
    Kettunen, Johannes
    ATHEROSCLEROSIS, 2020, 299 : 56 - 63